U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C21H26N8O4
Molecular Weight 454.4823
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-AMINO-N-(2,3-DIHYDRO-8-(3-((2-HYDROXYETHYL)AMINO)PROPOXY)-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-5-PYRIMIDINECARBOXAMIDE

SMILES

COC1=C2N=C(NC(=O)C3=CN=C(N)N=C3)N4CCN=C4C2=CC=C1OCCCNCCO

InChI

InChIKey=MRKSMBKRMJMBJR-UHFFFAOYSA-N
InChI=1S/C21H26N8O4/c1-32-17-15(33-10-2-5-23-7-9-30)4-3-14-16(17)27-21(29-8-6-24-18(14)29)28-19(31)13-11-25-20(22)26-12-13/h3-4,11-12,23,30H,2,5-10H2,1H3,(H2,22,25,26)(H,27,28,31)

HIDE SMILES / InChI

Molecular Formula C21H26N8O4
Molecular Weight 454.4823
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Tue Apr 01 23:14:41 GMT 2025
Edited
by admin
on Tue Apr 01 23:14:41 GMT 2025
Record UNII
QYB71X85N4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
COPANLISIB METABOLITE M3
Preferred Name English
2-AMINO-N-(2,3-DIHYDRO-8-(3-((2-HYDROXYETHYL)AMINO)PROPOXY)-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-5-PYRIMIDINECARBOXAMIDE
Systematic Name English
5-PYRIMIDINECARBOXAMIDE, 2-AMINO-N-(2,3-DIHYDRO-8-(3-((2-HYDROXYETHYL)AMINO)PROPOXY)-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-
Systematic Name English
Code System Code Type Description
CAS
2132943-81-6
Created by admin on Tue Apr 01 23:14:41 GMT 2025 , Edited by admin on Tue Apr 01 23:14:41 GMT 2025
PRIMARY
FDA UNII
QYB71X85N4
Created by admin on Tue Apr 01 23:14:41 GMT 2025 , Edited by admin on Tue Apr 01 23:14:41 GMT 2025
PRIMARY
PUBCHEM
130420807
Created by admin on Tue Apr 01 23:14:41 GMT 2025 , Edited by admin on Tue Apr 01 23:14:41 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
(DEALKYLATION BY CYP3A4), The six healthy male volunteers received a single i.v. infusion of 12 mg copanlisib (2.76 MBq (14C)copanlisib) in a total volume of 40 mL as a 1-h infusion in the morning, 1-h after a light breakfast. 5 Caucasians and 1 Asian with an age 54.8 +/- 5.2 yeas (mean +/- SD, range: 47-61 years) and a BMI of 24.8 kg/m^2. Non-smokers and reported at the most light alcohol use.
AMOUNT EXCRETED
FECAL